Insider Selling: STERIS (NYSE:STE) CEO Sells 1,374 Shares of Stock

STERIS plc (NYSE:STE) CEO Daniel Carestio sold 1,374 shares of STERIS stock in a transaction on Friday, June 5th. The stock was sold at an average price of $212.00, for a total value of $291,288.00. Following the completion of the sale, the chief executive officer directly owned 63,647 shares of the company’s stock, valued at $13,493,164. The trade was a 2.11% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

STERIS Stock Performance

Shares of STE traded down $2.16 during trading hours on Monday, hitting $210.19. The stock had a trading volume of 658,842 shares, compared to its average volume of 798,173. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.09 and a quick ratio of 1.54. STERIS plc has a 12 month low of $195.14 and a 12 month high of $269.44. The firm has a market capitalization of $20.51 billion, a PE ratio of 26.51 and a beta of 0.93. The stock has a fifty day moving average price of $217.24 and a 200 day moving average price of $238.96.

STERIS (NYSE:STE) last issued its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing the consensus estimate of $2.86 by ($0.03). STERIS had a return on equity of 14.15% and a net margin of 13.18%.The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the firm earned $2.74 EPS. The business’s revenue was up 6.7% on a year-over-year basis. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Analysts anticipate that STERIS plc will post 11.18 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 8th will be issued a $0.63 dividend. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. STERIS’s payout ratio is presently 31.78%.

Wall Street Analyst Weigh In

Several analysts recently commented on STE shares. KeyCorp cut their price objective on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a report on Wednesday, May 13th. Piper Sandler reissued an “overweight” rating and set a $270.00 price target on shares of STERIS in a report on Thursday, May 21st. Wall Street Zen lowered STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday. Finally, Weiss Ratings lowered STERIS from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 27th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $278.00.

Institutional Trading of STERIS

Hedge funds have recently bought and sold shares of the stock. Board of the Pension Protection Fund bought a new stake in STERIS during the fourth quarter valued at about $25,000. Western Wealth Management LLC bought a new stake in STERIS during the first quarter valued at about $25,000. Harbor Investment Advisory LLC boosted its stake in shares of STERIS by 115.4% in the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 60 shares during the period. Activest Wealth Management boosted its stake in shares of STERIS by 423.8% in the fourth quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 89 shares during the period. Finally, Measured Wealth Private Client Group LLC bought a new position in shares of STERIS in the fourth quarter worth about $28,000. Institutional investors own 94.69% of the company’s stock.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.